SecBot SecBot
8-K ·Filed Oct 2, 2026

PRCT

PROCEPT BioRobotics Corp
NEUTRAL
Impact 2/10
Horizonweeks Processed25d 6h ago SEC0001628280-26-064586
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine board appointment with no immediate catalyst. Monitor for any future committee assignments or strategic shifts in the surgical robotics space given Dr. Mack's FDA and cardiothoracic expertise.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
PRCT ▲ +9.82% at T+5d
NEUTRAL call +9.82% · α vs SPY +9.40% · entry $17.82 → $19.57
Next anchor: T+20d in 2d
Latest observation: T+14 +14.08% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
-1.74%
call -1.74% · α -2.29%
$17.51
settled 23d ago
T+5d
+9.82%
call +9.82% · α +9.40%
$19.57
settled 19d ago
T+20d
Pending
in 2d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

PROCEPT BioRobotics appointed Dr. Michael Mack as an independent Class II director, expanding the board from nine to ten members. Dr. Mack is a prominent cardiac surgeon with extensive leadership experience in thoracic surgery and FDA advisory roles. This is a routine board expansion with no financial impact.

Key Facts

  • Board size increased from 9 to 10 members
  • Dr. Michael Mack appointed as Class II independent director, effective October 2, 2026
  • Term expires at 2029 annual meeting
  • Dr. Mack is a cardiac surgeon, Chairman of Baylor Scott & White Research Institute, Co-Chair of FDA Heart Valve Collaboratory
  • Compensation consistent with non-employee director program; standard indemnification agreement

Financial Impact

No financial figures disclosed; director compensation is standard non-employee director program

Risk Factors

  • No material risk identified from this filing

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-064586
Document: 0001628280-26-064586-index-headers.html0001628280-26-064586
Document: 0001628280-26-064586-index.html0001628280-26-064586
Document: 0001628280-26-064586.txt0001628280-26-064586
13 reports for PRCT
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 5 of 5 best @ T+60▲ +22.73%Feb 26, 2026
Filters
Rows
Reports for PRCT — sortable, filterable
TypeNow
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 2/10
$17.82awaiting T+60—$19.80 (+11.11%)
Sep 24, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$17.20awaiting T+60—$19.80 (+15.12%)
Aug 10, 2026
11w ago
Insider Buy
BULLISH ★ 5/10
$21.71awaiting T+60—$19.80 (−8.80%)
Jun 11, 2026
19w ago
Institutional Cluster
MIXED ★ 4/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Mar 10, 2026
33w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.17 $26.33▲ +8.94%▼ −2.75%$19.80 (−18.08%)
Mar 6, 2026
33w ago
8-K
NEUTRAL ★ 3/10
$24.22 $27.86▲ +15.03%▲ +2.25%$19.80 (−18.25%)
Mar 6, 2026
33w ago
Insider Cluster
BULLISH ★ 7/10
$24.22 $27.86▲ +15.03%▲ +2.25%$19.80 (−18.25%)
Showing 10 of 13

US Market Status

Market Closed — Opens Thu (10h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026